Novel polyQ-length independent assay shows promise

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Sep 17 / Springer Healthcare

Novel polyQ-length independent assay shows promise

Neuroscience Huntington's Disease EHDN-2022

Description

Douglas Macdonald presents the details of a robust novel assay that can detect both the wild-type and the expanded mutant huntingtin protein in the cerebrospinal fluid of people with Huntington’s disease.

Follow us here

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.